Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)

Radiotherapy and Oncology

Volumn 88, Issue 2, 2008, Pages 183-191

  Henriksson, Roger ^a   Capala, Jacek ^b,c   Michanek, Annika ^d   Lindahl, Sten Åke ^e   Salford, Leif G ^f   Franzén, Lars ^a   Blomquist, Erik ^g   Westlin, Jan Erik ^h   Bergenheim, A Tommy ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Studsvik Medical Co   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e CENTRAL HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h Central Hospital   (Sweden)

Author keywords

BNCT; Glioblastoma; Quality of life; Survival; Toxicity

Indexed keywords

4 BORONOPHENYLALANINE; FRUCTOSE; TEMOZOLOMIDE;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MALE; MUCOSAL DISEASE; NEUTRON CAPTURE THERAPY; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION ABSORPTION; RADIATION DOSE; SEIZURE; SKIN DISEASE; SURVIVAL TIME; THROMBOEMBOLISM; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; BORON; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; FEMALE; FRUCTOSE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PHENYLALANINE; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 49149112762     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.04.015     Document Type: Article

References (24)

1. Aziz T., Press N.S., Diaz A.Z., Capala J., and Chanana A.D. Postmortem neuropathological features secondary to boron neutron capture therapy for glioblastoma multiforme. J Neuropath Exp Neurol 50 (2000) 62-73
2. Barth R.F. A critical assessment of boron neutron capture therapy: an overview. J Neurooncol 62 (2003) 61-74
3. Barth R.F., Grecula J.C., Yang W., et al. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys 1 (2004) 267-277
4. Barth R.F., and Joensuu H. Boron neutron capture therapy for the treatment of glioblastomas and extracranial tumours: as effective, more effective or less effective than photon irradiation?. Radiother Oncol 82 (2007) 119-122
5. Bauer W., Micca P., and White B. A rapid method for the direct analysis of boron in whole blood by atomic emission spectroscopy. Proceeding of the fifth international symposium on neutron capture therapy, columbus, OH. September 14-17 1992. In: Soloway A.H., Barth R.F., and Carpenter D.E. (Eds). Advances in Neutron Capture Therapy (1993), Plenum Pres, New York 403-407
6. Bergenheim A.T., Capala J., Roslin M., and Henriksson R. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol 71 (2005) 287-293
7. Busse M., Harling O.K., Palmer M.R., et al. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol 62 (2003) 111-121
8. Capala J., Stenstam B.H., Sköld K., et al. Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neurooncol 62 (2003) 133-144
9. Chanana A.D., Capala J., Chadha M., et al. Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies. Neurosurgery 44 (1999) 1182-1193
10. Chandra S., Smith D.R., and Morrisonm G.H. Subcellular imaging by dynamic SIMS ion microscopy. Anal Chem 72 (2000) 104A-114A
11. Coderre J.A., TM B., Micca P.L., Fisher C., Nawrocky M.M., and Liu H.B. Neutron capture therapy of the 9L rat gliosarcoma using the p- boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 30 (1994) 643-652
12. Coderre J.A., and Morris G.M. The radiation biology of boron neutron capture therapy. Radiat Res 151 (1999) 1-18
13. Diaz A.Z., Coderre J.A., Chanana A.D., and Ma R. Boron neutron capture therapy for malignant gliomas. Ann Med 32 (2000) 81-88
14. Diaz A.Z. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhave National Laboratory from a clinician's point of view. J Neurooncol 62 (2003) 101-109
15. Henriksson R., Malmström A., Bergström P., Bergh G., Trojanowski T., Andreasson L., et al. High grade astrocytoma treated concomitantly with estramustine and radiotherapy. J Neuro-oncol (2005)
16. Joel D.D., Coderre J.A., Micca P.L., and Naawrocky M.M. Effects of dose and infusion time on the delivery of p-boronophenyalanine for neutron captures therapy. J Neurooncol 41 (1999) 213-221
17. Joensuu H., Kankaanranta L., Seppälä T., et al. Boron neutron capture therapy of brain tumours: clinical trials at the Finnish facility using boronophenylalanine. J Neurooncol 62 (2003) 23-34
18. Morris G.M., Micca P.L., Nawrocky M.M., Weissfloch L.E., and Coderre J.A. Long-term infusions of -boronphenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models. Radiat Res 158 (2002) 743-752
19. Nakagawa Y., Pooh K., Kobayashi T., et al. Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J Neurooncol 62 (2003) 87-99
20. Nigg D.W., Wheeler F.J., Wessol D.E., Capala J., and Chadha M. Computational dosimetry and treatment planning for boron neutron capture therapy. J Neurooncol 33 (1997) 93-104
21. Shapiro W.R., Hiesiger E.M., Cooney G.A., Basler G.A., Lipschutz L.E., and Posner J.B. Temporal effects of dexamethasone on blood-to-brain and blood-to-tumour transport of 14C-alpha-aminoisobutyric acid in rat C6 glioma. J Neurooncol 8 (1990) 197-204
22. Smith D.R., Chandra S., Bart R.H., Yang W., Joel D.D., and Coderre J.A. Quantitative imaging and microlocalisation of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion spectroscopy: relevance to neutron capture therapy. Cancer Res 15 (2001) 81-88
23. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
24. Wittig A., Sauerwein W.A., and Coderre J.A. Mechanisms of transport of p-boronophenylalanine through the cell membrane in vitro. Rad Res 153 (2000) 173-180